Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

A$2.7m Equity Placement to Fund Laverton Drilling Campaign

by admin June 30, 2025
June 30, 2025
A$2.7m Equity Placement to Fund Laverton Drilling Campaign

Sarama Resources (SRR:AU) has announced A$2.7m Equity Placement to Fund Laverton Drilling Campaign

Download the PDF here.

This post appeared first on investingnews.com

previous post
Merger Discussions Between Brightstar and Aurumin
next post
A$4.5M Placement to Underpin Resource Growth Strategy

Related Posts

Goldgroup Enters Into Agreement To Sell Subsidiary Minera...

January 1, 2026

Managing Director Resignation and Board Changes

December 29, 2025

Tech Weekly: Investors Still Cautious on Tech Stocks...

December 13, 2025

Cygnus secures another two years to increase its...

April 2, 2025

Questcorp Mining Engages Marketing Consulting Firm Spark Newswire

July 2, 2025

Altech Batteries LtdCERENERGY Accredited Highest Possible Green Rating

January 24, 2025

Zinc Stocks: 5 Biggest Canadian Companies in 2025

January 1, 2026

Chris Vermeulen: Gold Signaling “Massive” Equities Correction, My...

October 22, 2025

WESTERN COPPER AND GOLD PROVIDES POSITIVE METALLURGICAL UPDATE

February 14, 2025

Sun Summit Minerals

January 19, 2026

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved